DETAILED NOTES ON SITUS JUDI MBL77

Not all people with CLL call for therapy. Inspite of all the latest improvements, the iwCLL even now endorses watchful observation for individuals with asymptomatic condition.86 This advice is based on at the very least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)